ePrescribing

Pros and Cons of Electronic Prior Authorizations, Prescribing

June 24, 2019 - A new rule from CMS calls for electronic prior authorization (ePA) updates, aiming to improve prescribers’ decision-making processes, ease administrative burden, and decrease the wait time for patients to receive prior authorization for a drug. The proposed rule would require that all Medicare Part D plans be equipped with the National...


More Articles

FTC Charges Surescripts with Monopolizing e-Prescribing Market

by Jessica Kent

The Federal Trade Commission (FTC) is suing Surescripts, alleging that the health information exchange company is using illegal vertical and horizontal restraints to maintain its monopoly over two key...

Proposed Rule Seeks Lower Medicare Advantage, Part D Drug Prices

by Kyle Murphy, PhD

CMS has opened comments on a proposed rule with the purpose of lowering the cost of prescription drugs and out-of-pocket expenses under Medicare Part C (Medicare Advantage) and Part D. The proposed...

Data from Health Plans, PBMs Helps Lower Prescription Drug Costs

by Chuck Green

The health information network Surescripts is using data from both payers and PBMs to give prescribers access to patient-specific and formulary-based benefit and cost information for nearly...

CVS Caremark Provides Real-Time Benefits Data to Pharmacies

by Thomas Beaton

CVS Caremark, the pharmacy benefit manager (PBM) of CVS Health, will provide pharmacies and prescribers with real-time benefits data on patients as a way to reduce payer and patient drug costs, the...

HFPP Provides New Resource for Payers to Combat Opioid Abuse

by Thomas Beaton

A new 64-page report from the Healthcare Fraud Prevention Partnership (HFPP), a public-private partnership which includes CMS, gives payers resources that treat, educate, and develop improvements for...